Registration gives the benefit of receiving regular site update emails.
ADHD Institute Register

ADHD is a lifelong disorder

ADHD is a chronic neurodevelopmental disorder which can affect children, adolescents and adults

Read more

The neurobiology of ADHD
is highly complex

Evidence exists for the association between ADHD and possible structural, functional and neurotransmitter alterations in various regions of the brain in children, adolescents and adults with ADHD

Read more

Assessment and diagnosis

ADHD assessment involves clinical examination, interviews and rating scales. Formal ADHD diagnosis typically utilises DSM-5TM or ICD-10 classification systems

Read more

Guidelines

Clinical guidelines are available to provide evidence-based recommendations for the management of ADHD to help guide appropriate and rational choices of treatment

Read more

Optimal management of ADHD

The optimal management of ADHD process should always consider input from the patient, family/caregivers and school to help establish an appropriate and extensive treatment programme (non-pharmacological and pharmacological therapy), goals and assessment/follow-up, resulting in a tailored multimodal treatment plan centred on the patient

Read more

Attention-deficit hyperactivity disorder (ADHD) is a diverse condition characterised by symptoms of inattention, hyperactivity and impulsivity; and can have a significant impact on patients’ lives. This website provides educational resources intended for healthcare professionals outside the US with an interest in ADHD. It aims to share scientific advances in ADHD research and provide expert opinions and medical education to support the healthcare professional community.

Filter content by:

Animation: Adult ADHD and the brain

Imaging studies suggest that ADHD is typically associated with some structural abnormalities in the brain

WCADHD 2017 - Day 4

6th World Congress on ADHD: From child to adult disorder. Vancouver, Canada, 20-23 April 2017

WCADHD 2017 - Day 3

6th World Congress on ADHD: From child to adult disorder. Vancouver, Canada, 20-23 April 2017

WCADHD 2017 - Day 2

6th World Congress on ADHD: From child to adult disorder. Vancouver, Canada, 20-23 April 2017

WCADHD 2017 - Day 1

6th World Congress on ADHD: From child to adult disorder. Vancouver, Canada, 20-23 April 2017

Interactive module: Rating scale toolkit

An overview of rating scales used in the assessment of patients with ADHD

eLearning module: Treatment of child, adolescent and adult ADHD

Diagnosis and initial assessment of ADHD

Meeting of Minds 2016
Vienna, Austria, 6–7 June

Animation: Childhood/Adolescent ADHD and the brain by Dr Mitual Mehta

Interactive module: ADHD across the ages

EUNETHYDIS 2016

EUNETHYDIS 4th International Conference: ADHD – from basic neuroscience to optimised clinical care

Are there difficult areas of the day when control of ADHD symptoms is particularly important for children and adolescents with ADHD? | Professor Peter Hill

Patient-centred management: every patient is different with unique needs – a Spanish perspective. Part 2: Treatment plans for children and adolescents

Adherence to treatment

Adherence to ADHD medication is often suboptimal, and can be encouraged by psychoeducation and the patient's acceptance of their condition

Assessment and Diagnosis

ADHD assessment involves clinical examination, interviews and rating scales

Impact of ADHD

ADHD can negatively impact the lives of patients and their families, affecting education, employment, finances and relationships

Key congress 2017

Major International and European congresses focusing on mental health and psychiatry

Neurobiology

ADHD is associated with structural, functional and neurotransmitter alterations in the brain

Are there difficult areas of the day when control of ADHD symptoms is particularly important for children and adolescents with ADHD? | Dr Robert Findling

Comorbidities

Psychiatric comorbidities are common in patients with ADHD, including bipolar disorder, major depression, substance abuse disorder, anxiety and phobias

Guidelines

Evidence-based or consensus-driven guidelines for the treatment of ADHD help consolidate practice internationally

ADULT ADHD: Burden and Diagnosis

eLearning Module on the burden and diagnosis of adult ADHD, supported by Professor Philip Asherson, is now available.

A leap forward for adult ADHD screening

Shaw P et al. JAMA Psychiatry 2017; 74: 527

27 Apr 2017

ADHD in adolescence – the lost generation?

Buitelaar JK. Epidemiol Psychiatr Sci 2017; 17: 1-5

20 Apr 2017

Familial relationships are integral for ADHD treatment in adolescents with ADHD

Uçar HN et al. J Atten Disord 2017; Epub ahead of print

13 Apr 2017

A new adult ADHD screening scale for DSM-5TM

Ustun B et al. JAMA Psychiatry 2017; 74: 520-526

7 Apr 2017

Treatment of ADHD symptoms in parents may improve ADHD treatment outcomes in children

Chronis-Tuscano A et al. J Abnorm Child Psychol 2017; 45: 501-517

3 Apr 2017

Prevalence of ADHD medication use increases in children and adolescents in Europe

Bachmann CJ et al. Eur Neuropsychopharmacol 2017; Epub ahead of print

30 Mar 2017

Familial aggregation of ADHD increases with increasing genetic relatedness

Chen Q et al. J Child Psychol Psychiatry 2017; 58: 231-239

23 Mar 2017

Are gene–environment interactions involved in shaping the ADHD phenotype?

van der Meer D et al. J Psychiatry Neurosci 2017; 42: 113-121

16 Mar 2017


ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Shire has no influence or control over the content of this third party website.

Continue Cancel